Formulated nucleic acid compositions and methods of administering the same for gene therapy
US6514947B2 · kind B2 · utility
10Cited by
15References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 11, 1997 |
| Grant date | Feb 4, 2003 |
| Priority date | — |
| Expiry date | Feb 11, 2017 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions and methods for administering nucleic acid compositions in vitro to cells in culture or in vivo to an organism whereby the uptake of nucleic acids is enhanced are provided. Various compositions, including those incorporating protective, interactive, non-condensing compounds, are utilized to protect and administered nucleic acid formulation, thereby prolonging the localized bioavailability of the administered nucleic acid and enhancing expression from the nucleic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.